Table 2.
Patient outcomes
| Complete cohort (N = 75) | Active treatment cohort (N = 59) | |||
|---|---|---|---|---|
| 6-month all-cause mortalitya | 6-month unfavorable outcome* | 6-month all-cause mortalitya | 6-month unfavorable outcome* | |
| Overall | 34 (45%) | 46 (61%) | 18 (31%) | 30 (51%) |
| Center subgroups | ||||
| Helsinki | 27 (46%) | 35 (59%) | 11 (26%) | 19 (44%) |
| Stockholm | 7 (44%) | 11 (69%) | 7 (44%) | 11 (69%) |
| Age subgroups | ||||
| ≤ 40 years | 14 (39%) | 17 (47%) | 7 (24%) | 10 (35%) |
| 41–60 years | 9 (32%) | 18 (64%) | 3 (14%) | 12 (55%) |
| > 60 years | 11 (100%) | 11 (100%) | 8 (100%) | 8 (100%) |
| Weapon subgroups | ||||
| Firearm | 31 (61%) | 38 (75%) | 15 (43%) | 22 (63%) |
| Nail gun | 1 (10%) | 2 (20%) | 1 (10%) | 2 (20%) |
| Sharp object | 2 (20%) | 5 (50%) | 2 (20%) | 5 (50%) |
| Other | 0 | 1 (25%) | 0 | 1 (25%) |
| Self-inflicted subgroups | ||||
| Yes | 25 (52%) | 32 (67%) | 14 (38%) | 21 (57%) |
| No | 8 (32%) | 12 (48%) | 3 (15%) | 7 (35%) |
| GCS subgroups | ||||
| 3–8 | 31 (78%) | 34 (85%) | 15 (63%) | 18 (75%) |
| 9–12 | 2 (20%) | 6 (60%) | 2 (20%) | 6 (60%) |
| 13–15 | 1 (4%) | 5 (21%) | 1 (4%) | 5 (21%) |
GCS, Glasgow Coma Scale; GOS, Glasgow Outcome Scale
aIdentical to 30-day all-cause mortality
*Defined as GOS 1–3; missing for 4 patients; median time to follow-up for 6-month survivors was 302 days (IQR 188–388 days)